Musculoskeletal Diseases Treatment Market Forecast 2031

The musculoskeletal diseases treatment market size is projected to reach US$ 7.90 billion by 2031 from US$ 5.23 billion in 2023. The market is expected to register a CAGR of 5.30% during 2023–2031. Advances in imaging technology and rising interventional procedures are likely to remain key trends in the musculoskeletal disease treatment market.

Musculoskeletal Diseases Treatment Market Analysis

Musculoskeletal diseases refer to the group of disorders that adversely affect muscles, joints, bones, and other human body parts. Tendinitis, osteoarthritis, spondylitis, and osteoporosis are among the most common musculoskeletal diseases. Doctors often diagnose musculoskeletal diseases majorly based on the medical history of a patient or by performing several physical examinations. Key factors driving the musculoskeletal disease treatmentmarket are the rising prevalence of musculoskeletal disorders, the increasing elderly population, and technological advancements in musculoskeletal disease diagnosis. However, the high cost of diagnostic systems and the unavailability of skilled professionals hinder the growth of the market.

Musculoskeletal Diseases Treatment Market Overview

North America is the largest market for musculoskeletal disease treatments with the US holding the largest regional market share, followed by Canada. The market growth in North America is driven by the increasing demand for innovative products from ultrasound, PET, SPECT, and magnetic resonance imaging companies; the presence of key market players; and extensive R&D conducted by various academic and research institutes. Moreover, the rising focus on advanced method incorporation in healthcare, government and private initiatives for the promotion of early diagnosis, and massive funds from government and private bodies for musculoskeletal research contribute to revenue generation for the musculoskeletal diseases treatment market in North America. The revenue generation and the global economic position of North America in the global musculoskeletal diseases treatment market.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Musculoskeletal Diseases Treatment Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Musculoskeletal Diseases Treatment Market Drivers and Opportunities

Rising Prevalence of Musculoskeletal Disorders Favors Market

Sports injuries, occupational injuries, and age-related dysfunction can cause musculoskeletal disorders.  Back pain, rheumatoid arthritis, osteoarthritis, osteoporosis, septic arthritis, gout, myasthenia gravis, and systemic lupus erythematous (SLE) are among the most common musculoskeletal diseases. The musculoskeletal system is the diagnosis and management of all acute and chronic conditions adversely affecting the musculoskeletal system, including bones, muscles, tendons, joints, and ligaments, and the treatment of non-surgical lesions of the musculoskeletal system. Almost 300,000 babies and children are affected by arthritis or a rheumatic condition. The common type of arthritis is osteoarthritis, which affects ∼31 million Americans. By the end of 2040, number of people expected to have doctor-diagnosed arthritis will be above 78 million. Thus, the rising prevalence of musculoskeletal diseases drives the the musculoskeletal diseases treatment market growth.

Development of Hybrid Diagnostic Systems

Hybrid MRI systems refer to the process of complex minimally invasive imaging techniques that combine two modalities to provide information on the anatomy and physiology of the human body. The MRI can be combined with various other imaging techniques, including computed tomography (CT) and positron emission tomography (PET), or simple tools available for imaging, such as X-ray fluoroscopy. Multi-modal imaging has become specifically essential as modern diagnostic techniques are concentrated toward molecular and genetic levels. The combination of PET and MRI has proven to be highly successful over the past decade in basic clinical and preclinical research. These hybrids are progressing into clinical applications to provide insights into various medical conditions, diseases, biologic pathways, and therapeutic assessment.

Musculoskeletal Diseases Treatment Market Report Segmentation Analysis

Key segments that contributed to the derivation of the musculoskeletal diseases treatment market analysis are disease and imaging modality.

• Based on disease, the musculoskeletal diseases treatment market is segmented into arthritis, osteoarthritis, osteoporosis, spondylitis, and others. The arthritis segment held the largest market share in 2023.
• By imaging modality, the market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and others. The computed tomography (CT) segment held the largest share of the market in 2023.

Musculoskeletal Diseases Treatment Market Share Analysis by Geography

The geographic scope of the musculoskeletal diseases treatment market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America.

North America dominated the musculoskeletal diseases treatment market. For several millions of Americans, the quality of healthcare is symbolized by the quality of radiologic care available in their region. According to the American Society of Radiologic Technologists 2023, ∼275 million conventional radiology procedures are performed annually in the US. Government regulations are made to test and label the passive implants for safety and compatibility in the magnetic resonance (MR) environment. In the US, the Division of Radiological Health within the US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) provides the safety and effectiveness of medical devices and the safety of radiation-emitting electronic products. Moreover, the US government has decided to tighten the reins of ultrasound machines and similar imaging equipment to prevent the abuse of these machines for sex selection and other issues.

Musculoskeletal Diseases Treatment Market Regional Insights

The regional trends and factors influencing the Musculoskeletal Diseases Treatment Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Musculoskeletal Diseases Treatment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Musculoskeletal Diseases Treatment Market Report Scope

Musculoskeletal Diseases Treatment Market Players Density: Understanding Its Impact on Business Dynamics

The Musculoskeletal Diseases Treatment Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Musculoskeletal Diseases Treatment Market are:

1. GENERAL ELECTRIC
2. KONINKLIJKE PHILIPS N.V.
3. SIEMENS AG
4. CANON MEDICAL SYSTEMS CORPORATION
5. Hitachi, Ltd
6. Accuray Incorporated

Disclaimer: The companies listed above are not ranked in any particular order.

Musculoskeletal Diseases Treatment Market News and Recent Developments

The musculoskeletal diseases treatment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the musculoskeletal diseases treatment market are listed below:

• Solera Health launched its new Musculoskeletal (MSK) offering through top digital MSK therapy solutions—SWORD Health, Kaia Health, and Sworkit. The company claims that its new MSK offering will address a continuum of musculoskeletal conditions through sub-clinical services spanning preventative wellness, injury, and chronic condition management, as well as preoperative and postoperative rehabilitation through its expanding network of top-notch, evidence-based digital interventions. (Source: Solera Health, Press Release, 2021)

Musculoskeletal Diseases Treatment Market Report Coverage and Deliverables

The “Musculoskeletal Diseases Treatment Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Musculoskeletal diseases treatment market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Musculoskeletal diseases treatment market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Musculoskeletal diseases treatment market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the musculoskeletal diseases treatment market
• Detailed company profiles